Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Vascular Anomalies and Treatments

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the diagnosis and management of hereditary hemorrhagic telangiectasia (HHT), a genetic disorder characterized by vascular malformations. It covers topics such as genetics, pulmonary arteriovenous malformations, embolization, epistaxis, liver involvement, SMAD4 mutations, and vascular anomalies.

94
Works

How has Vascular Anomalies and Treatments's publication output changed over time?

ScholarIQpublication output · 1996–2022

Output declined50% over the shown period — from 2 works in 1996 to 1 in 2022.

2
1
2
1
1
1
2
2
1
1
1996200720092013201420152019202020212022

What are the most-cited papers on Vascular Anomalies and Treatments?

ScholarIQmost cited works
Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1
Kimberly A. McAllister, K.M. Grogg, David W. Johnson, Carol J. Gallione, Melanie A. Baldwin, Charles E. Jackson, E.A. Helmbold, Dorene S. Markel, Wendy McKinnon, J. Murrel, Mary Kay McCormick, M. A. Pericak‐Vance, Peter Heutink, Ben A. Oostra, T. Haitjema, C.J.J. Westerman, Mary Porteous, Alan E. Guttmacher, Michelle Letarte, Douglas A. Marchuk
S137905309. 19941,503 CitationsOPEN ACCESS
Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2
David W. Johnson, Jonathan Berg, Melanie A. Baldwin, Carol J. Gallione, Ivonne Marondel, Sang-Heon Yoon, Timothy T. Stenzel, Marcy C. Speer, M. A. Pericak‐Vance, Austin G. Diamond, Alan E. Guttmacher, Charles E. Jackson, Liliana Attisano, Raju Kucherlapati, Mary Porteous, Douglas A. Marchuk
S137905309. 19961,130 Citations
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia
Marie E. Faughnan, Valerie A. Palda, Guadalupe García–Tsao, Urban W. Geisthoff, Jamie McDonald, Deborah D. Proctor, John C. Spears, Dale Brown, Elisabetta Buscarini, Mark S. Chesnutt, Vincent Cottin, Arupa Ganguly, James R. Gossage, Alan E. Guttmacher, Robert H. Hyland, Shelley Kennedy, Joshua R. Korzenik, Johannes J. Mager, Augustin Ozanne, Jay F. Piccirillo, Daniel Picus, Henri Plauchu, Mary Porteous, Reed E. Pyeritz, Douglas A. Ross, Carlo Sabbà, Karen L. Swanson, P. B. Terry, M. Christopher Wallace, C. J. J. Westermann, Robert I. White, Lawrence H. Young, Roberto Zarrabeitia
S112540174. 20091,081 Citations
Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia
Vincent Cottin, Thierry Chinet, A. Lavolé, R. Corre, Éric Marchand, Martine Reynaud‐Gaubert, Henri Plauchu, Jean-François Cordier
Medicine. 2007215 CitationsOPEN ACCESS
Clinical Practice Guideline: Nosebleed (Epistaxis)
David E. Tunkel, Samantha Anne, Spencer C. Payne, Stacey L. Ishman, Richard M. Rosenfeld, Peter J. Abramson, Jacqueline D. Alikhaani, Margo McKenna Benoit, Rachel S. Bercovitz, Michael D. Brown, Boris Chernobilsky, David Feldstein, Jesse M. Hackell, Eric H. Holbrook, Sarah M. Holdsworth, Kenneth W. Lin, Meredith Merz Lind, David M. Poetker, Charles A. Riley, John S. Schneider, Michael D. Seidman, Venu Vadlamudi, Tulio A. Valdez, Lorraine C. Nnacheta, Taskin M. Monjur
Otolaryngology. 2020194 Citations

Where is Vascular Anomalies and Treatments research published, and who funds it?

ScholarIQvenues & funding sources

TOP JOURNALS

S1379053092,633
S1125401741,081
S2764583368168

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Vascular Anomalies and Treatments is open access?

ScholarIQopen access share
40%OPEN ACCESS
Gold
13%
Green
20%
Hybrid
0%
Bronze
7%
Closed
60%

Related on ScholarIQ

Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1
Paper
Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial
Paper
Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2
Paper
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia
Paper
A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
Paper
Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Paper
470M+ articles · free account